Chris Hansis, MD, PhD
Founder & CEO
Dr. Chris Hansis is the Founder & CEO of Phase Clinical Services, a full-service CRO in Mt. Kisco, New York concentrating on Phase 0-II oncology clinical trials. Previously he was the Founder & CEO of the preclinical research services provider TransCell Science until its acquisition by BioIVT, for which he served as the Chief Scientific Officer. He was also Research Faculty, Principal Investigator, and Director at the University of Southern California and New York University Medical Schools, focusing on the generation of human embryonic stem and iPS cells and molecular lineage determination in preimplantation embryos.